Adrenalino terapija - Company finances
|
EUR
|
2023
From: 2023-04-27
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 32,505 | 20,828 | 23,029 |
| Profit before tax | 0 | 0 | 0 |
| Net profit | 0 | 0 | 0 |
| Equity | 300 | 300 | 300 |
| Liabilities | 200 | 253 | 533 |
| Non-current assets | 6,897 | 5,763 | 6,134 |
| Current assets | 198 | 10 | 293 |
| Total assets | 7,095 | 5,773 | 6,427 |
|
Financial indicators
|
|||
| Revenue change y/y | - | -35.9% | +10.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 0.0% | 0.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.0% | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.0% | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.8 | 1.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Adrenalino terapija - Social security debts
The company had no debts to Sodra
Adrenalino terapija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Adrenalino terapija, VšI (code 306304963) is a Public Institution operating in amusement and recreation activities n.e.c. In the latest financial year, 2025, the company generated revenue of EUR 23.0K, up 10.6% year on year from EUR 20.8K in 2024. Over the longer 2023–2025 period, revenue moved from EUR 32.5K in 2023 to EUR 20.8K in 2024 and then recovered moderately in 2025, though it remained below the 2023 level by 29.1%. The balance sheet stayed very small, with total assets of EUR 6.4K in 2025, compared with EUR 5.8K in 2024 and EUR 7.1K in 2023. Equity was unchanged at EUR 300 across all three years, while liabilities increased to EUR 533 in 2025 from EUR 253 in 2024 and EUR 200 in 2023. Most assets were long-term assets, at EUR 6.1K in 2025, while short-term assets were EUR 293. The equity ratio was 4.7%, debt-to-equity was 1.78, and asset turnover stood at 3.58x, indicating a small asset base generating relatively high turnover.